When PISCES data is released, Merck will have the validation they are waiting for with Oncosec. Positive data will give them the green light to either expand their collaboration with Oncosec to other indications, a licensing deal in melanoma or a flat out buyout deal. If it happens it happens, all depends on PISCES data. Nobody will know until later this year. If the data is good I think the stock price will be much higher. In the meantime the market seems a little worried and the price has declined. Hopefully we hear about TNBC partnering to stop the bleeding. Tomorrow is Rocky Mountain Bio Conference and Oncosec will present. Maybe we see a bounce tomorrow.
News 
Market Data 
Discover 
